Луциус Мирдаметиниб – Купить онлайн
Луциус Мирдаметиниб – Купить онлайн

Луциус Мирдаметиниб – Купить онлайн

EUR 563.29

1,500+ vendidos
Precio especial

Farmacia fisica en Hong Kong, 100% de autenticidad garantizada

Puntos clave

(Mirdametinib) MEK1 MEK2 ，

Garantias del servicio

Envio directo transfronterizoFarmacia autorizadaRevisado por farmaceuticoGarantia de autenticidad

Especificaciones

Especificacion
1mg*42 capsulas/caja
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong

10000 disponibles

Categoría: Marca:

Informacion del producto

Nombre en ingles
Mirdametinib
Nombre generico
Mirdametinib

Especificaciones

Especificacion
1mg*42 capsulas/caja
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong

Detalles completos

Indicaciones

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mecanismo de accion

Mirdametinib Como funciona Como funciona ，

Dosis

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precauciones (5.1)] (EF)[ Precauciones (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precauciones

5 Precauciones GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI

Package Insert

Ingredients

11 GOMEKLI (R)-N-(2,3- )-3,4- -2-((2- -4- ) ) C16H14F3IN2O4， 482.20 g/mol ， 25°C 0.25 mg/mL，pH 7.2 pKa 7.96

Indications

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Dosis

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precauciones (5.1)] (EF)[ Precauciones (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precautions

5 Precauciones GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI

Use in Pregnancy and Lactation

8.1 Como funciona[ (12.1)] ，GOMEKLI - ， mirdametinib， - ， (BSA) 2 mg/m²， ， 2% 4% 15% 20%

Clinical Pharmacology

12 12.1 Como funciona 1 2 (MEK1/2) MEK1/2 (ERK) ， MEK1 MEK2 ERK NF1 ， ERK ， 12.2 -

Pharmacology and Toxicology

13 13.1 6 rasH2 ， 5 mg/kg AUC ， 2 mg/m² 15 Ames ， 1 ， 28

Clinical Studies

6.1 ， ， Precauciones Descripción ReNeu [ (14)] n=114 NF-106 n=19 [NCT-02096471] 133 75 58 GOMEKLI 28 21 GOMEKLI 2 mg/m²， ， GOMEKLI 133 ，62% ，38% ，12%

Resenas del producto (17)

Filtro: Todas las resenas
4.8★★★★★
17 resenas de clientes14 compras verificadas
+o***e· 3周前
★★★★
+t***3· 1个月前
Compra verificada
★★★★★

Descripcion

Indicaciones

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mecanismo de accion

Mirdametinib Como funciona Como funciona ，

Dosis

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precauciones (5.1)] (EF)[ Precauciones (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precauciones

5 Precauciones GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI